34. Dupilumab Treatment in Patients With Hand and Foot Atopic Dermatitis: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

¹Oregon Health & Science University, Portland, OR, USA;

²The George Washington School of Medicine and Health Sciences, Washington, DC, USA;

³Charité-Universitätsmedizin Berlin, Berlin, Germany;

⁴Stanford University School of Medicine, Redwood City, CA, USA;

⁵Kyoto Prefectural University of Medicine, Kyoto, Japan;

⁶Andrzej Mielęcki Memorial Independent Public Clinical Hospital, Katowice, Poland;

⁷Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA;

⁸Sanofi, Chilly-Mazarin, France